SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
114 hedge funds and large institutions have $39.6M invested in SANGAMO THERAPEUTICS INC in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 24 closing their positions.
15% more capital invested
Capital invested by funds: $34.5M → $39.6M (+$5.15M)
8.02% more ownership
Funds ownership: 23.39% → 31.41% (+8%)
4% more call options, than puts
Call options by funds: $756K | Put options by funds: $727K
6% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 32
7% less funds holding
Funds holding: 122 → 114 (-8)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.18M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$760K |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$722K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$379K |
| 5 |
Squarepoint
New York
|
+$365K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.31M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$692K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$615K |
| 4 |
Millennium Management
New York
|
-$480K |
| 5 |
Goldman Sachs
New York
|
-$459K |
SGMO Hedge Fund Activity: Q2 2025 in Review
114 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2025, worth a combined $39.6M — up 15% from $34.5M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of SGMO and 17 opened new positions — a net loss of 7 holders — while 32 trimmed existing stakes and 30 added.
The largest buyer was Renaissance Technologies, adding an estimated $2.18M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $1.31M sold.
- 114 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2025, down from 122 in Q1 2025.
- Funds reported $39.6M of SANGAMO THERAPEUTICS INC stock for Q2 2025, up 15% quarter-over-quarter.
- 17 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2025 and 24 closed out, a net change of -7 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q2 2025 was Renaissance Technologies, an estimated $2.18M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q2 2025 was Point72 Asset Management, an estimated $1.31M sold.
Based on aggregated 13F filings for Q2 2025.